50 employees
ArcoScreen is a Swiss medtech is developing a new microfluidic discovery platform for drug screening targeting cell membrane receptors.
2021
$164K
from 1 investors over 1 rounds
ArcoScreen raised $164K on August 25, 2021
Investors: Venture Kick